Human papillomavirus type-distribution in condylomata acuminata of mainland China: A meta-analysis

International Journal of STD and AIDS

Volumn 19, Issue 10, 2008, Pages 680-684

  Wang, H ^a   Qiao, Y L ^a  

^a CANCER HOSPITAL   (China)

Author keywords

China; Condylomata acuminata; Genital warts; HPV; PCR

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; CHINA; CONDYLOMA ACUMINATUM; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 40; HUMAN PAPILLOMAVIRUS TYPE 42; HUMAN PAPILLOMAVIRUS TYPE 43; HUMAN PAPILLOMAVIRUS TYPE 44; HUMAN PAPILLOMAVIRUS TYPE 6; LOGISTIC REGRESSION ANALYSIS; META ANALYSIS; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; WART VIRUS;

CASE-CONTROL STUDIES; CHINA; CONDYLOMATA ACUMINATA; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; POLYMERASE CHAIN REACTION; PREVALENCE; SPECIES SPECIFICITY; TREATMENT OUTCOME; VACCINATION;

EID: 53549125265     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2008.008040     Document Type: Article

References (16)

1. Rotkin ID. A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents. Cancer Res 1973;33:1353-67
2. zur Hausen H. Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol 1977;78:1-30
3. Center for Disease Control and Prevention, Workowski KA, Berman SM, Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006;55:62-7
4. Beutner KR, Becker TM, Stone KM. Epidemiology of human papillomavirus infections. Dermatol Clin 1991;9:211-8
5. Gissmann L, Wolnik L, Ikenberg H, Koldovsky U, Schnürch HG, zur Hausen H. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci USA 1983;80:560-3
6. Gissmann L, deVilliers EM, zur Hausen H. Analysis of human genital warts (condylomata acuminata) and other genital rumors for human papillomavirus type 6 DNA. Int J Cancer 1982;29:143-6
7. Lacey CJ, Goodall RL, Tennvall GR, et al. Randomized controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts. Sex Transm Infect 2003;79:270-5
8. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88:63-73
9. Clifford GM, Smith JS, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003;89:101-5
10. Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1157-64
11. Bao YP, Li N, Smith JS, et al. Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis. Int J STD AIDS In Review
12. Brown DR, Schroeder JM, Bryan JT, Stoler MH, Fife KH. Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 1999;37:3316-22
13. Forslund O, Hansson BG. Human papillomavirus type 70 genome cloned from overlapping PCR products: complete nucleotide sequence and genomic organization. J Clin Microbiol 1996;34:802-9
14. Lorincz AT, Quinn AP, Goldsborough MD, Schmidt BJ, Temple GF. Cloning and partial DNA sequencing of two new human papillomavirus types associated with condylomas and low-grade cervical neoplasia. J Virol 1989;63:2829- 34
15. Iftner T, Villa LL. Chapter 12: Human papillomavirus technologies. J Natl Cancer Inst Monogr 2003;31:80-8
16. Burk RD, Kelly P, Feldman J, et al. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transtn Dis 1996;23:333-41